Children's Hospital of Los Angeles - Therapeutic Hypothermia After Pediatric Cardiac Arrest (THAPCA) Trials

Hypothesis, Study Design, Inclusion and Exclusion Criteria
__________________________________________________

Research Hypotheses for the THAPCA Trial:
Therapeutic Hypothermia (TH) will improve survival and neurobehavioral outcome following out-of-hospital CA in children (THAPCA-OH Trial) (similar to adult OH RCTs); and TH will improve survival and neurobehavioral outcome following in-hospital CA in children (THAPCA-IH Trial)

Safety hypothesis for THAPCA Trials: TH will not increase (a) all-cause 28 day mortality, (b) incidence of infections, (c) arrhythmias, and (d) blood product administration within 7 days of CA in either in-hospital or out-of-hospital cohorts

Study Design:  
Conceptually simple RCT(s) proposed; One intervention (Hypothermia vs Control); Two treatment strata (Out-of-hospital; In-hospital)

THPCA Schema

Link to the Inclusion and Exclusion Criteria

This study is funded by the NIH - National Heart Lung and Blood Institute.

Link to the to main Therapeutic Hypothermia Website.